xanthorrhizol has been researched along with Skin Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, WY; Hwang, JK; Kim, HO; Kim, MJ; Lee, SK; Park, JH; Park, KK | 1 |
1 other study(ies) available for xanthorrhizol and Skin Neoplasms
| Article | Year |
|---|---|
Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-acti
Topics: Acute Disease; Animals; Anticarcinogenic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Ear; Edema; Female; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Neoplasm Staging; NF-kappa B; Nitric Oxide Synthase Type II; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Phenols; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2007 |